Aurobindo Pharma

BSE : 524804 | NSE : AUROPHARMA

Industry : Pharmaceuticals | ISIN : INE406A01037 | FreeFloat : 47.89% | FnO : Yes | LotSize : 1000


Intellectual Capital (IC)9,419.91
Net Worth (NW)25,540.66
Intrinsic Worth (IW)34,960.57
Market Cap (MC)29,918.03
Economic Value Added-733.92
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)26.94%
IC Gross Margin (EBITDA/IC)41.96%
IC Net Margin (NPT/IC)25.17%
Knowledge Turnover (Sales/IC)2.57
Market to Intrinsic Value (MC/IW)0.86

As OfIntrinsic ValueMarket Price
30 Sep 2022Rs. 596.66Rs. 510.60
30 Jan 2023 ---- Rs. 411.35
-5.00     -1.22%
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : NoSell10 DMA : Rs. 435.27SellStrong Sell
KB > 50% : No50 DMA : Rs. 447.67
0 < M2IV < 1 : YesVol-Price trend : Falling
Disclaimer: Stock outlook is based on data calculations only and does NOT constitute investment advice.

Question 3 - Is this stock undervalued?


Question 2 - Does this business have significant knowledge assets?


Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.

Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Dec-19
C
5895.00
5925.93
1225.41
975.28
938.17
705.31
816.53
Mar-20
C
6158.43
6191.02
1341.75
1109.34
1077.51
848.99
997.73
Jun-20
C
3419.70
3545.28
1090.41
970.62
960.19
714.68
711.55
Sep-20
C
6483.44
6537.19
1466.03
1208.69
1192.98
805.65
762.79
Dec-20
C
6364.91
6498.31
1487.52
1211.00
1191.51
876.46
950.86
Mar-21
C
6001.50
6079.60
1345.09
1079.09
1060.87
801.18
719.81
Jun-21
C
5701.98
5811.88
1310.28
1030.59
1017.71
769.97
989.99
Sep-21
C
5941.92
6038.50
1272.25
978.04
967.62
696.71
581.43
Dec-21
C
5989.43
6002.22
1108.96
809.91
793.78
604.29
537.19
Mar-22
C
5795.34
5809.37
1019.17
765.60
756.39
576.14
794.21
Jun-22
C
6235.92
6276.54
973.13
693.62
678.99
520.38
703.36
Sep-22
C
5739.37
5796.56
846.75
548.65
523.36
410.37
483.99
* C - Consolidated, S - Standalone